Celldex Therapeutics, Inc. Marketable Securities, Current in USD from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Celldex Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2010 to Q3 2025.
  • Celldex Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $547M, a 24% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Celldex Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $547M -$172M -24% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $607M -$152M -20% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $656M -$52.6M -7.42% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $697M +$308M +79.3% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $720M +$505M +236% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $760M +$535M +238% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $709M +$485M +216% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $389M +$113M +41.1% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $214M -$90.7M -29.7% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $224M -$104M -31.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $224M -$131M -36.9% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $276M -$93.6M -25.4% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $305M -$46M -13.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $328M +$208M +172% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $355M +$248M +233% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $369M +$219M +145% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $351M +$169M +93.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $121M -$18.3M -13.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $107M +$75.8M +244% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $151M +$97.4M +183% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $181M +$125M +222% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $139M +$77.3M +125% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $31M Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $53.2M -$16.6M -23.8% Dec 31, 2019 10-K 2021-03-29
Q3 2019 $56.3M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $61.6M Jun 30, 2019 10-Q 2019-08-07
Q4 2018 $69.7M Dec 31, 2018 10-K 2020-03-26
Q1 2012 $69.4M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $41.4M +$1.6M +4.02% Dec 31, 2011 10-Q 2012-05-04
Q3 2011 $49.7M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $60.4M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $39.8M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.